Biktarvy

Biktarvy is a combination medication used in the treatment of HIV-1 infection. It contains emtricitabine, tenofovir alafenamide, and bictegravir, offering a convenient once-daily oral option for managing HIV.

Biktarvy is primarily used for the treatment of HIV-1 infection in adults and children who weigh at least 25 kg. This medication is designed to help control the virus and reduce the risk of HIV-related complications. It is often prescribed as part of a comprehensive treatment plan that includes other medications and lifestyle changes.

Common effects of Biktarvy may include nausea, diarrhea, and headache. Some individuals might experience changes in liver function or bone density. It is important to monitor for any unusual symptoms and consult a healthcare provider if concerns arise.

Biktarvy should be handled with care, especially for individuals with a history of liver disease or kidney problems. Regular monitoring of liver function and kidney health is recommended. Always follow the guidance of a healthcare professional when using this medication.

Biktarvy may interact with other medications, including certain antacids, rifampin, and other drugs that affect liver enzymes. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions.